Gender effects on health care costs in cardiovascular medicine-a black box?
Related Experiment Video
Updated: May 16, 2026
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Helmut Gulbins1, Beatrice Vogel, Hermann Reichenspurner
1Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany. h.gulbins@uke.de
Insights
Women incur higher lifetime healthcare costs, partly due to pregnancy. In cardiovascular medicine, metabolic syndrome impacts women more, yet they receive less preventive care, increasing treatment costs and affecting prognosis.
Area of Science:
- Medical Economics
- Cardiovascular Medicine
- Health Disparities
Background:
- Gender-based differences in disease prevalence and impact are well-documented.
- These disparities can significantly affect healthcare costs and reimbursement models.
Purpose of the Study:
- To analyze the economic implications of gender-related differences in cardiovascular medicine.
- To investigate how gender influences healthcare costs and treatment outcomes in cardiovascular diseases.
Main Methods:
- A systematic literature review was conducted.
- The review focused on studies examining the impact of gender on healthcare costs, specifically within cardiovascular medicine.
Main Results:
- Women incur higher lifetime healthcare costs, with a portion attributable to pregnancy and childbirth.
- Excluding pregnancy costs, a residual cost difference favoring higher expenses for women persists, though its origin is unclear.
- Metabolic syndrome and diabetes, prevalent in women, have a greater impact on cardiovascular disease (CVD) costs and outcomes compared to men.
- Despite higher risk, women receive suboptimal preventive care for metabolic syndrome, impacting hospital treatment costs and prognosis after procedures like coronary bypass grafting.
Conclusions:
- Improved preventive strategies are needed for female patients, particularly addressing the heightened influence of risk factors on CVD.
- Further research is essential to provide robust evidence on gender-specific impacts of risk factors on treatment costs.
- Findings could inform adjustments to reimbursement strategies to account for gender disparities in cardiovascular care.
Introduction:
Gender differences were documented for several diseases. This might influence treatment costs for the insurance companies as well as reimbursement of the health care facilities. This manuscript deals with the possible economic implications of gender-related differences in cardiovascular medicine.
Methods:
A systematical review of the literature reporting the impact of gender on health care costs with special focus on cardiovascular medicine.
Results:
Women cause higher health care costs during their lifetime, but large part of the difference compared with men is caused by pregnancy and birth, not by diseases. However, after subtracting the costs for pregnancy and birth, there still remains a difference with higher costs for women, although the origin of this disparity is not definitely clear up to date. In cardiovascular medicine, especially the risk factor metabolic syndrome including diabetes had a higher prevalence in women and was shown to have a greater impact on cardiovascular disease compared with men. This concerned both costs and outcome. But in contrast to this, women experienced poorer preventive treatment of their metabolic syndrome, especially with regards to lipid levels. This influenced the costs of hospital treatment as well as the prognosis, for example, following coronary bypass grafting.
Comments:
The higher influence of several risk factors on cardiovascular disease in women should lead to improved preventive strategies in female patients. Further research is necessary to give more evidence for gender-related differences within the impact of several risk factors on treatment costs. This could then also influence reimbursement strategies taking these gender disparities into account.
More Related Videos
06:55Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Related Concept Videos
01:29Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
01:29Bias in Epidemiological Studies
01:23Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
01:18Factors Affecting Illness
For instance, risk factors are connected to illness, disability,...